Palisade Bio Net Debt Growth & History (PALI)
Palisade Bio's net debt was −$133.4M for fiscal 2025.
View full Palisade Bio company overviewPalisade Bio annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$133.4M | −$123.7M | — |
| 2024 | 2024-12-31 | −$9.7M | $2.5M | — |
| 2023 | 2023-12-31 | −$12.2M | −$154,000 | — |
| 2022 | 2022-12-31 | −$12.1M | −$1.8M | — |
| 2021 | 2021-12-31 | −$10.3M | −$11.0M | — |
| 2020 | 2020-12-31 | $708,000 | $5.7M | — |
| 2019 | 2019-12-31 | −$5.0M | — | — |
| 2016 | 2016-12-31 | −$11.5M | −$14.7M | — |
| 2015 | 2015-12-31 | $3.2M | $6.9M | — |
| 2014 | 2014-12-31 | −$3.7M | $5.4M | — |
| 2013 | 2013-12-31 | −$9.1M | −$1.7M | — |
| 2012 | 2012-12-31 | −$7.4M | — | — |
Palisade Bio quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$125.2M | −$119.8M | — |
| Q1 2026 | 2026-03-31 | −$132.6M | −$125.5M | — |
| Q4 2025 | 2025-12-31 | −$133.4M | −$123.7M | — |
| Q3 2025 | 2025-09-30 | −$5.2M | $2.7M | — |
| Q2 2025 | 2025-06-30 | −$5.4M | $5.8M | — |
| Q1 2025 | 2025-03-31 | −$7.2M | $3.9M | — |
| Q4 2024 | 2024-12-31 | −$9.7M | $2.5M | — |
| Q3 2024 | 2024-09-30 | −$7.9M | $7.2M | — |
| Q2 2024 | 2024-06-30 | −$11.2M | $4.9M | — |
| Q1 2024 | 2024-03-31 | −$11.1M | $1.9M | — |
| Q4 2023 | 2023-12-31 | −$12.2M | −$154,000 | — |
| Q3 2023 | 2023-09-30 | −$15.1M | −$1.4M | — |
| Q2 2023 | 2023-06-30 | −$16.1M | −$11.5M | — |
| Q1 2023 | 2023-03-31 | −$13.0M | −$6.4M | — |
| Q4 2022 | 2022-12-31 | −$12.1M | −$1.8M | — |
| Q3 2022 | 2022-09-30 | −$13.6M | −$267,000 | — |
| Q2 2022 | 2022-06-30 | −$4.6M | $6.7M | — |
| Q1 2022 | 2022-03-31 | −$6.6M | — | — |
| Q4 2021 | 2021-12-31 | −$10.3M | −$11.0M | — |
| Q3 2021 | 2021-09-30 | −$13.4M | — | — |
| Q2 2021 | 2021-06-30 | −$11.3M | −$9.9M | — |
| Q4 2020 | 2020-12-31 | $708,000 | $5.7M | — |
| Q2 2020 | 2020-06-30 | −$1.4M | — | — |
| Q1 2020 | 2020-03-31 | −$9.9M | — | — |
| Q4 2019 | 2019-12-31 | −$5.0M | — | — |
| Q3 2019 | 2019-09-30 | −$7.1M | — | — |
| Q1 2017 | 2017-03-31 | −$9.1M | −$8.5M | — |
| Q4 2016 | 2016-12-31 | −$11.5M | −$14.7M | — |
| Q3 2016 | 2016-09-30 | −$846,701 | $3.2M | — |
| Q2 2016 | 2016-06-30 | −$5.2M | −$5.6M | — |
| Q1 2016 | 2016-03-31 | −$608,369 | $4.1M | — |
| Q4 2015 | 2015-12-31 | $3.2M | $6.9M | — |
| Q3 2015 | 2015-09-30 | −$4.0M | $2.2M | — |
| Q2 2015 | 2015-06-30 | $333,664 | $9.2M | — |
| Q1 2015 | 2015-03-31 | −$4.7M | $6.6M | — |
| Q4 2014 | 2014-12-31 | −$3.7M | $5.4M | — |
| Q3 2014 | 2014-09-30 | −$6.3M | $2.5M | — |
| Q2 2014 | 2014-06-30 | −$8.9M | −$5.3M | — |
| Q1 2014 | 2014-03-31 | −$11.3M | −$6.2M | — |
| Q4 2013 | 2013-12-31 | −$9.1M | −$1.7M | — |
| Q3 2013 | 2013-09-30 | −$8.8M | — | — |
| Q2 2013 | 2013-06-30 | −$3.6M | — | — |
| Q1 2013 | 2013-03-31 | −$5.1M | — | — |
| Q4 2012 | 2012-12-31 | −$7.4M | — | — |
Palisade Bio net debt trends
Over the last five fiscal years, Palisade Bio's net debt decreased from $708,000 to −$133.4M, a change of −$134.1M. The latest reported quarter, Q2 2026, shows −$125.2M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Palisade Bio source filings ↗